As part of our “Employee Spotlight: New Hire” series, we welcome Moises Daniel, Software Engineer to share highlights of his first 3 months of working at Osmind.
View older posts
Dr. L. Alison McInnes provides an introduction to sublingual ketamine troches for home use through the lens of evidence-based medicine
Dr. Carlene MacMillan shares four foundational steps for psychiatrists interested in opening their own private practice
Dr. L. Alison McInnes discusses ways for busy clinicians to empower ketamine infusion therapy patients with measurement-based care
Pragmatic ways that clinicians can implement measurement-based care into their ketamine practices to positively affect patient engagement and retention.
When it comes to mental health care, especially the care of more chronic or complex conditions, many patients work with a multidisciplinary team of helpers.
Dr. Alison McInnes discusses how clinicians can implement measurement-based care into their practices to build a stronger therapeutic alliance with treatment-resistant depression patients and improve their outcomes
Dr. Carlene MacMillan shares tips for working with insurance and addressing coverage with patients in your mental health practice.
Dr. McInnes discusses whether clinicians who provide PAT should have a personal experience with the treatment before administering it to their patients.
Osmind introduces its first Public Benefit Corporation Report, which includes details about the company’s activities and progress toward advancing mental health interventions.
Lucia Huang, co-founder, and CEO of Osmind, discusses the company’s Series B funding and ongoing commitment to responsible innovation and research toward new mental health treatments.
Jimmy Qian, co-founder and COO of Osmind, introduces the new Osmind logo and brand.
The Ketamine and Related Compounds International Hybrid Conference held in Oxford was attended by many academics who made landmark discoveries in the rapid-acting antidepressant (RAAD) space. Dr. Alison McInnes shares the main takeaways from the conference.
Carlene MacMillan, VP of Clinical Innovation at Osmind, guides you through the new DSM-5-TR, and outlines the changes that stand out.
It’s critical for your clinical practice to stay current with the newest research literature, but it can be hard to keep up. The Evidence Base aims to help clinicians follow the developments that advance evidence-based mental health practices.
If you recently added Spravato® treatment to your practice services, it’s likely your qualified patients will have important questions before they begin treatment sessions.
If you’re starting up a clinic or adding interventional mental health services to your practice, including ketamine therapy, SPRAVATO(R), psychedelic medicine, or neuromodulation such as TMS, an EHR that can handle specialized treatments and workflows will save you time and help you deliver a better patient experience.
Several recent key studies show promising evidence that support digital device use and passive sensing in the treatment of depression. Almost everything we do now in modern life generates data - and we can learn from it.
Make it easy to see appointments and events across your practice by connecting your Osmind EHR with your Google Calendars. Osmind practices can now easily sync appointments and events between a clinician’s Google Calendar and the Osmind EHR, directly from the Schedule tab within Osmind.
If you’re starting a new practice that offers innovative treatments such as ketamine infusions and TMS, you’ll need to ask critical questions before selecting your malpractice insurance carrier and coverage.
Over a year ago, when things were really bad in his life, Sean tried ketamine therapy. Ketamine is a legal anesthetic that is approved by the FDA.
We’re excited to announce our partnership with the American Association for Precision Medicine (AAPM)!
On September 30, 2020, the Osmind team hosted an AMA (“Ask Me Anything”) on the Osmind forum with Paul Austin.
“At one point or another, each and every one of us will benefit from the care and protection provided by our emergency services.”- Prince William
We’re excited to announce today that MoodMonitor is merging into Osmind.
On Thursday, July 30th, 2020, we hosted a video AMA on the Osmind community with Andrew Penn
The field of psychedelics has seen an explosion of new organizations and interests. At Osmind, we’re building the digital infrastructure that’s